N/A
N=8,299
The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening
Hepatitis B
Bottom Line
View on ClinicalTrials.gov: NCT04240678 ↗Enrolled (actual)
8,299
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcome: Primary: Serum Hepatitis B Surface Antigen Completion — 389; 177 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Electronic HBV Alert (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of California, Davis
- Primary completion
- Jul 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Serum Hepatitis B Surface Antigen Completion |
389; 177 | — |
| SECONDARY Serum Hepatitis B Surface Antigen Positivity |
15; 13 | — |
Summary
Asian and Pacific Islander Americans at risk, but never tested for chronic hepatitis B have been randomized to receive an electronic alert in their electronic medical chart to remind primary care physicians to screen them for chronic hepatitis B.
Eligibility Criteria
Inclusion Criteria: Asian and Pacific Islanders (API) who have not yet received HBsAg testing. API will be identified using a novel algorithm which identifies them using their surname, language preference, country of origin.
-
Exclusion Criteria: Previous HBsAg completion.
-
Data sourced from ClinicalTrials.gov (NCT04240678). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.